First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience

Randomized phase III trials have shown significant improvement of survival 1, 2, and 3 years after implantation of 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) wafers for patients with newly diagnosed malignant glioma. But these studies and subsequent non-phase III studies have also shown risks asso...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Bock, Hans Christoph, Puchner, Maximilian Josef Anton, Lohmann, Frauke, Schütze, Michael, Koll, Simone, Ketter, Ralf, Buchalla, Ruediger, Rainov, Nikolai, Kantelhardt, Sven R., Rohde, Veit, Giese, Alf
Format: Artigo
Jezik:Inglês
Izdano: Springer-Verlag 2010
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2936684/
https://ncbi.nlm.nih.gov/pubmed/20706757
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10143-010-0280-7
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki